Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Scandinavian Journal of Rheumatology
|
May 10, 2017
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
E Berthold, B Månsson, B Gullstrand, et al.
The Journal of Clinical Investigation
|
August 1, 1994
An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome
C Ståhl-Hallengren, T Ukkonen, K Kainulainen, et al.
Arthritis Care & Research
|
May 28, 2010
Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register
L E Kristensen, J A Karlsson, M Englund, et al.
Vaccine
|
December 10, 2022
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis
J Nagel, G Jönsson, J-Å Nilsson, et al.
Annals of the Rheumatic Diseases
|
December 16, 1998
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study
T Conrozier, T Saxne, C S Fan, et al.
Annals of the Rheumatic Diseases
|
March 14, 2009
Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden
A Gülfe, L E Kristensen, T Saxne, et al.
Rheumatology (Oxford, England)
|
September 5, 2002
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats
E Larsson, H Erlandsson Harris, J C Lorentzen, et al.
British Journal of Rheumatology
|
April 1, 1995
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
M Sharif, T Saxne, L Shepstone, et al.
Annals of the Rheumatic Diseases
|
December 1, 1994
Cartilage metabolism in the injured and uninjured knee of the same patient
L Dahlberg, H Roos, T Saxne, et al.
Rheumatology International
|
January 1, 1988
The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis
K Hørslev-Petersen, T Saxne, D Haar, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Scandinavian Journal of Rheumatology
|
May 10, 2017
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
E Berthold, B Månsson, B Gullstrand, et al.
The Journal of Clinical Investigation
|
August 1, 1994
An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome
C Ståhl-Hallengren, T Ukkonen, K Kainulainen, et al.
Arthritis Care & Research
|
May 28, 2010
Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register
L E Kristensen, J A Karlsson, M Englund, et al.
Vaccine
|
December 10, 2022
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis
J Nagel, G Jönsson, J-Å Nilsson, et al.
Annals of the Rheumatic Diseases
|
December 16, 1998
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study
T Conrozier, T Saxne, C S Fan, et al.
Annals of the Rheumatic Diseases
|
March 14, 2009
Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden
A Gülfe, L E Kristensen, T Saxne, et al.
Rheumatology (Oxford, England)
|
September 5, 2002
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats
E Larsson, H Erlandsson Harris, J C Lorentzen, et al.
British Journal of Rheumatology
|
April 1, 1995
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
M Sharif, T Saxne, L Shepstone, et al.
Annals of the Rheumatic Diseases
|
December 1, 1994
Cartilage metabolism in the injured and uninjured knee of the same patient
L Dahlberg, H Roos, T Saxne, et al.
Rheumatology International
|
January 1, 1988
The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis
K Hørslev-Petersen, T Saxne, D Haar, et al.
Page
of 12